I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Catenacci, Daniel VT
94
results:
Search for persons
X
Format
Online (94)
Mediatypes
Articles (Online) (79)
Bookchapter (Online) (1)
OpenAccess-fulltext (14)
Sorted by: Relevance
Sorted by: Year
?
1
Bemarituzumab With Modified Folfox6 For Advanced Fgfr2-Posi..:
Catenacci, Daniel VT
;
Tesfaye, Anteneh
;
Tejani, Mohamed
...
Future Oncology. 15 (2019) 18 - p. 2073-2082 , 2019
Link:
https://doi.org/10.2217/..
?
2
Perioperative therapy for locally advanced gastroesophageal..:
Sehdev, Amikar
;
Catenacci, Daniel VT
Journal of Hematology & Oncology. 6 (2013) 1 - p. , 2013
Link:
https://doi.org/10.1186/..
?
3
Analysis of Circulating Tumor DNA to Predict Risk of Recurr..:
Huffman, Brandon M
;
Aushev, Vasily N
;
Budde, Griffin L
...
qt5xh3q3cv. , 2022
Link:
https://escholarship.org..
?
4
Correction: Phase II Study Evaluating 2 Dosing Schedules of..:
Shah, Manish A
;
Wainberg, Zev A
;
Catenacci, Daniel VT
...
qt33x007wx. , 2022
Link:
https://escholarship.org..
?
5
A PERFECT biomarker-focused study of neoadjuvant IO for eso..:
Catenacci, Daniel VT
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197732/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
6
Personalized Antibodies for Gastroesophageal Adenocarcinoma..:
Catenacci, Daniel VT
;
Moya, Stephanie
;
Lomnicki, Samantha
...
qt008397m0. , 2021
Link:
https://escholarship.org..
?
7
Correction: Phase II Study Evaluating 2 Dosing Schedules of..:
Shah, Manish A
;
Wainberg, Zev A
;
Catenacci, Daniel VT
...
qt4vr1q63k. , 2021
Link:
https://escholarship.org..
?
8
Exploring New Approaches for Locally Advanced Gastroesophag..:
Catenacci, Daniel VT
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639623/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Phase I Escalation and Expansion Study of Bemarituzumab (FP..:
Catenacci, Daniel VT
;
Rasco, Drew
;
Lee, Jeeyun
...
qt47d6q5nb. , 2020
Link:
https://escholarship.org..
?
10
Safety and Efficacy of Durvalumab and Tremelimumab Alone or..:
Kelly, Ronan J
;
Lee, Jeeyun
;
Bang, Yung-Jue
...
qt6007x2ph. , 2020
Link:
https://escholarship.org..
?
11
Initial Report of Second‐Line FOLFIRI in Combination with R..:
Klempner, Samuel J
;
Maron, Steven B
;
Chase, Leah
...
qt5qr8p0td. , 2019
Link:
https://escholarship.org..
?
12
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncom..:
Klempner, Samuel J
;
Madison, Russell
;
Pujara, Vivek
...
qt6tf0t557. , 2019
Link:
https://escholarship.org..
?
13
Tumor genome analysis includes germline genome: Are we read..:
Catenacci, Daniel VT
;
Amico, Andrea L
;
Nielsen, Sarah M
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2015
Link:
http://www.ncbi.nlm.nih...
?
14
Perioperative therapy for locally advanced gastroesophageal..:
Sehdev, Amikar
;
Catenacci, Daniel VT
http://www.jhoonline.org/content/6/1/66. , 2013
Link:
http://www.jhoonline.org..
?
15
A randomized pilot phase I study of modified carcinoembryon..:
Geynisman, Daniel M
;
Zha, Yuanyuan
;
Kunnavakkam, Rangesh
...
http://www.immunotherapyofcancer.org/content/1/1/8. , 2013
Link:
http://www.immunotherapy..
1-15